Magentus Managing Director to continue shaping national policy on interoperability, clinician usability and responsible AI in health software
Michele Blanshard, Managing Director, Practice Management & Oncology at Magentus, has been re-elected to the Board of the Medical Software Industry Association (MSIA) for a second consecutive term. She continues as MSIA Vice President, the role she was first elected to in October 2025.
The MSIA is Australia’s peak body for health software providers. It represents the companies that build the clinical, administrative and diagnostic software Australian healthcare providers rely on. It also works with government and the health sector on digital health policy, interoperability, cybersecurity, data governance and the responsible use of emerging technologies such as AI.
Michele returns to the Board as cloud platforms, AI and interoperability reshape how care is delivered. The sector’s challenge is making sure these changes reduce the workload on clinicians rather than add to it.
A year of progress
In her first term, Michele focused on three priorities:
- interoperability across primary, specialist and hospital care;
- software designed around clinical workflow that reduces administrative burden;
- the ethical adoption of AI.
In December 2025, the MSIA and the Medical Technology Association of Australia (MTAA) launched Australia’s first voluntary code of conduct for AI in health software. The code sets a governance baseline for software that sits outside the TGA’s regulatory remit, including practice management and clinical workflow systems. In February 2026, Magentus became its first signatory.
“When clinicians have the right information at the right time, they spend less time navigating technology and more time with patients. That’s the test every piece of health software should pass, including AI,” Michele said.
Priorities for the next term
Michele said healthcare becoming increasingly connected creates opportunities to improve how information flows across the system.
She added that organisations such as the MSIA are becoming more important as the industry navigates the opportunities presented by cloud technologies, artificial intelligence and growing expectations for interoperability.
“There’s real momentum across Australian health technology. Our job as an industry is to make sure innovation is practical, trusted and makes a measurable difference for providers and patients. The MSIA brings together the voices needed to do that.”
A practical perspective
At Magentus, Michele leads the practice management and oncology businesses. These include Gentu, the cloud-based practice management platform, Genie, and Charm Evolution, the leading oncology information management system used by oncology services across Australia and New Zealand. With Magentus practice management software used by two-thirds of Australian specialists, Michele has a direct view of the pressures specialist practices and cancer services face when adopting new technology.
Magentus congratulates Michele on her reappointment and will continue to support the MSIA’s work toward a more connected and sustainable digital health system for all Australians.
